EcoDrugPlus

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSTTRG00000001968
Gene Symbol: PIM1
1 Cross references
244 Possible Orthologues:

Pim-2 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSTTRG00000004747
Gene Symbol: PIM2
1 Cross references
115 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSTTRG00000017162
Gene Symbol: PIM3
1 Cross references
217 Possible Orthologues:

Rar Related Orphan Receptor C

Ensembl ID : ENSTTRG00000003151
Gene Symbol: RORC
1 Cross references
382 Possible Orthologues:

Rela Proto-Oncogene, Nf-Kb Subunit

Ensembl ID : ENSTTRG00000002311
Gene Symbol: RELA
1 Cross references
199 Possible Orthologues:

Ros Proto-Oncogene 1, Receptor Tyrosine Kinase

Ensembl ID : ENSTTRG00000011071
Gene Symbol: ROS1
1 Cross references
124 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSTTRG00000015192
Gene Symbol: ROCK1
1 Cross references
215 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSTTRG00000013165
Gene Symbol: ROCK2
1 Cross references
304 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSTTRG00000005695
Gene Symbol: SRC
1 Cross references
262 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSTTRG00000005441
Gene Symbol: TEK
1 Cross references
164 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSTTRG00000002949
Gene Symbol: TTK
3 Cross references
203 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSTTRG00000016672
Gene Symbol: YES1
1 Cross references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).